Breast cancer circulating biomarkers: advantages, drawbacks, and new insights
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights
Authors
Keywords
Breast cancer circulating biomarkers, Breast cancer liquid biopsy, Circulating DNA, Circulating microRNA, Circulating tumor cells, Microvesicles and exosomes
Journal
TUMOR BIOLOGY
Volume 36, Issue 9, Pages 6653-6665
Publisher
Springer Nature
Online
2015-08-25
DOI
10.1007/s13277-015-3944-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
- (2015) M. Malvezzi et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer
- (2015) Marcilei EC Buim et al. CANCER BIOLOGY & THERAPY
- Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancer
- (2015) Dorit Di Gioia et al. CLINICA CHIMICA ACTA
- Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
- (2015) Corinna Eichelser et al. Oncotarget
- The immunogenicity of breast cancer--molecular subtypes matter
- (2014) C. Denkert ANNALS OF ONCOLOGY
- Molecular characterization of exosome-like vesicles from breast cancer cells
- (2014) Stefan Kruger et al. BMC CANCER
- Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
- (2014) Sae Byul Lee et al. BMC CANCER
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
- (2014) Marek Sochor et al. BMC CANCER
- Formation and role of exosomes in cancer
- (2014) Lindsey T. Brinton et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
- (2014) Simone Anfossi et al. PLoS One
- Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer
- (2014) In Hae Park et al. TUMOR BIOLOGY
- Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
- (2014) Natalia Krawczyk et al. Biomed Research International
- Dielectrophoretic Capture and Genetic Analysis of Single Neuroblastoma Tumor Cells
- (2014) Erica L. Carpenter et al. Frontiers in Oncology
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers
- (2013) Jun Sang Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
- (2013) D J E Peeters et al. BRITISH JOURNAL OF CANCER
- Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy
- (2013) Linda M. Johnson et al. CANCER BIOLOGY & THERAPY
- Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
- (2013) Francesco Fabbri et al. CANCER LETTERS
- Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
- (2013) G. Curigliano et al. CLINICAL CANCER RESEARCH
- Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
- (2013) M. Chan et al. CLINICAL CANCER RESEARCH
- Biomarkers in the treatment of cancer: opportunities and pitfalls
- (2013) Bohuslav Melichar CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
- (2013) Enders K. O. Ng et al. PLoS One
- The Oncogenic Role of microRNA-130a/301a/454 in Human Colorectal Cancer via Targeting Smad4 Expression
- (2013) Lin Liu et al. PLoS One
- The roles of extracellular vesicles in cancer biology: Toward the development of novel cancer biomarkers
- (2013) Takeshi Katsuda et al. PROTEOMICS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer
- (2012) J. S. Lee et al. ANNALS OF ONCOLOGY
- Immunotherapy in Breast Cancer Towards a New Understanding of Both Tumor and Host
- (2012) Peter C. Dubsky et al. Breast Care
- Circulating Tumor Cells (CTCs) Detected by Triple-Marker EpCAM, CK19, and hMAM RT-PCR and Their Relation to Clinical Outcome in Metastatic Breast Cancer Patients
- (2012) Shu Zhao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer
- (2012) G. Fiorucci et al. CURRENT MEDICINAL CHEMISTRY
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
- (2012) A L Smith et al. ONCOGENE
- The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers
- (2012) Weijie Chen et al. TUMOR BIOLOGY
- A Systematic Review of Barriers to Breast Cancer Care in Developing Countries Resulting in Delayed Patient Presentation
- (2012) Ketan Sharma et al. Journal of Oncology
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
- (2011) Mina J Bissell et al. NATURE MEDICINE
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
- (2010) Ruth E. Board et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Nucleic Acids: Perspective in Breast Cancer
- (2010) Ida Casciano et al. Breast Care
- CA 15-3: Uses and limitation as a biomarker for breast cancer
- (2010) Michael J. Duffy et al. CLINICA CHIMICA ACTA
- Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
- (2010) Fengjun Wang et al. GYNECOLOGIC ONCOLOGY
- Microvesicles: mediators of extracellular communication during cancer progression
- (2010) V. Muralidharan-Chari et al. JOURNAL OF CELL SCIENCE
- HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
- (2010) E. M. de Kruijf et al. JOURNAL OF IMMUNOLOGY
- A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
- (2010) Hua Zhao et al. PLoS One
- Beyond the increasing complexity of the immunomodulatory HLA-G molecule
- (2008) E. D. Carosella et al. BLOOD
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells
- (2008) R. Rizzo et al. CYTOTHERAPY
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA miR-328 Regulates Zonation Morphogenesis by Targeting CD44 Expression
- (2008) Chia-Hui Wang et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now